Pharmaceutical composition comprising a pyrazolopyrimidine and cyclodextrin

Pharmaceutical compositions comprising at least a substituted pyrazolo[1,5-a]pyrimidine compound (P) or a pharmaceutically acceptable salt or a stereoisomeric form thereof, and at least one pharmaceutically acceptable cyclodextrin derivative (C), and optionally one or several further components (F), such as a co-solvent, have unexpected stabilities.